Monosialoganglioside GM1
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Monosialoganglioside GM1, covering 2015-07-17 to 2016-06-01. Get the full timeline:
Most recent: Clinical Trial Update: Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC Patients [Phase 3]